article thumbnail

Laura Loomer Loses Litigation (Again)–Loomer v. Zuckerberg

Technology & Marketing Law Blog

Second, the plaintiff has not cognizably alleged that Twitter and Facebook’s manipulating or editing users’ content contributes to any illegality. I’m sure this ruling won’t the last one in this case or in Loomer’s broader litigation campaign. The post Laura Loomer Loses Litigation (Again)–Loomer v.

article thumbnail

Event reminder - Pharma and Biotech Patent Litigation Summit

The IPKat

New acquisition: Merpel and Girl with a Pearl Earring As The IPKat reported a while ago, on 22-24 January 2024, the Pharma and Biotech Patent Litigation Summit will return to Amsterdam (Netherlands). A UPC Litigation Forum will take place on 22 January too. Speakers include judges from the UK, EPO, USA and the UPC.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pharma and Biotech Patent Litigation Summit returns to Amsterdam with IPKat readers’ discount

The IPKat

Amsterdam Kat The IPKat has learned that on, 22-24 January 2023, the Pharma and Biotech Patent Litigation Summit will return to the Anantara Grand Hotel Krasnapolsky in Amsterdam (Netherlands). A UPC Litigation Forum will take place on 22 January too. The IPKat has negotiated a special discount for readers.

article thumbnail

Now Available! Updated Goodwin’s Guide to Biosimilars Litigation and Regulation in the U.S., 2023-2024

LexBlog IP

.” Since the enactment of the BPCIA, the FDA has approved 46 biosimilar products, and, as the market has grown, litigation activity concerning biosimilars has increased rapidly. We are excited to announce that Goodwin has released an updated edition of our guide published by Thomson Reuters. The post Now Available!

article thumbnail

Announcing the 2023 Edition of My Internet Law Casebook

Technology & Marketing Law Blog

I’m pleased to announce the 2023 edition (14th edition) of my Internet Law casebook, Internet Law: Cases & Materials. Meanwhile, product design is the real Section 230 battlefront today, and the Lemmon case is the flagship case for that line of litigation. All printed versions come with a free PDF on request.] Lopez (Cal.

Editing 52
article thumbnail

Can Teaming IBM’s blockchain with Spangenberg’s IPwe Turn Patents Into a Trillion-Dollar Market?

IP Close Up

IBM and IPwe, believe that NFTs, Non-Fungible Tokens – one-of-a-kind limited digital editions – can transform stagnant patent monetization into a trillion dollar market. Two IP icons Continue reading.

article thumbnail

Fish & Richardson Receives Top Rankings in 2021 Edition of IAM Patent 1000: The World’s Leading Patent Professionals

Fish & Richardson Trademark & Copyright Thoughts

Fish & Richardson has received the elite “Gold Band” national ranking in the Litigation category in the 2021 edition of IAM Patent 1000: The World’s Leading Patent Professionals. also received top rankings in the Prosecution and Litigation categories. also received top rankings in the Prosecution and Litigation categories.

Editing 97